Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Current Opinion in Drug Discovery & Development
|
April 18, 2007
DARPins: a true alternative to antibodies
Michael T Stumpp, Patrick Amstutz
Nature Methods
|
March 1, 2007
Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target
Christian Zahnd, Patrick Amstutz, Andreas Plückthun
Nature Biotechnology
|
October 8, 2005
Engineering novel binding proteins from nonimmunoglobulin domains
H Kaspar Binz, Patrick Amstutz, Andreas Plückthun
The Journal of Biological Chemistry
|
October 20, 2006
Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening
Martin Kawe, Patrik Forrer, Patrick Amstutz, et al.
Drug Discovery Today
|
July 16, 2008
DARPins: a new generation of protein therapeutics
Michael T Stumpp, H Kaspar Binz, Patrick Amstutz
Plos Biology
|
December 30, 2006
Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors
Gaby Sennhauser, Patrick Amstutz, Christophe Briand, et al.
Journal of Molecular Biology
|
August 18, 2009
DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage
Alexander Eggel, Michael J Baumann, Patrick Amstutz, et al.
Journal of Molecular Biology
|
September 2, 2003
Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins
H Kaspar Binz, Michael T Stumpp, Patrik Forrer, et al.
The Journal of Biological Chemistry
|
February 3, 2004
Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity
Christian Zahnd, Silvia Spinelli, Béatrice Luginbühl, et al.
Protein Engineering, Design & Selection : PEDS
|
March 23, 2006
Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries
Patrick Amstutz, Holger Koch, H Kaspar Binz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Current Opinion in Drug Discovery & Development
|
April 18, 2007
DARPins: a true alternative to antibodies
Michael T Stumpp, Patrick Amstutz
Nature Methods
|
March 1, 2007
Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target
Christian Zahnd, Patrick Amstutz, Andreas Plückthun
Nature Biotechnology
|
October 8, 2005
Engineering novel binding proteins from nonimmunoglobulin domains
H Kaspar Binz, Patrick Amstutz, Andreas Plückthun
The Journal of Biological Chemistry
|
October 20, 2006
Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening
Martin Kawe, Patrik Forrer, Patrick Amstutz, et al.
Drug Discovery Today
|
July 16, 2008
DARPins: a new generation of protein therapeutics
Michael T Stumpp, H Kaspar Binz, Patrick Amstutz
Plos Biology
|
December 30, 2006
Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors
Gaby Sennhauser, Patrick Amstutz, Christophe Briand, et al.
Journal of Molecular Biology
|
August 18, 2009
DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage
Alexander Eggel, Michael J Baumann, Patrick Amstutz, et al.
Journal of Molecular Biology
|
September 2, 2003
Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins
H Kaspar Binz, Michael T Stumpp, Patrik Forrer, et al.
The Journal of Biological Chemistry
|
February 3, 2004
Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity
Christian Zahnd, Silvia Spinelli, Béatrice Luginbühl, et al.
Protein Engineering, Design & Selection : PEDS
|
March 23, 2006
Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries
Patrick Amstutz, Holger Koch, H Kaspar Binz, et al.
Page
of 2